NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 355.12%
S&P500 52-Week Change 318.53%
52 Week High 3119.65
52 Week Low 366.71
50-Day Moving Average 3109.38
200-Day Moving Average 395.42

Share Statistics

Avg Vol (3 month) 3837.61k
Avg Vol (10 day) 3979.48k
Shares Outstanding 592.09M
Float 90.85M
% Held by Insiders 11.27%
% Held by Institutions 1105.09%
Shares Short (Nov 29, 2019) 44.34M
Short Ratio (Nov 29, 2019) 43.94
Short % of Float (Nov 29, 2019) 46.39%
Short % of Shares Outstanding (Nov 29, 2019) 44.71%
Shares Short (prior month Oct 31, 2019) 43.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 29, 1995
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 3.12%
Operating Margin (ttm)25.34%

Management Effectiveness

Return on Assets (ttm)10.13%
Return on Equity (ttm)4.13%

Income Statement

Revenue (ttm)675.57M
Revenue Per Share (ttm)7.40
Quarterly Revenue Growth (yoy)46.30%
Gross Profit (ttm)393.45M
EBITDA 177.85M
Net Income Avi to Common (ttm)21.09M
Diluted EPS (ttm)0.22
Quarterly Earnings Growth (yoy)6.00%

Balance Sheet

Total Cash (mrq)670.16M
Total Cash Per Share (mrq)7.28
Total Debt (mrq)486.23M
Total Debt/Equity (mrq)84.63
Current Ratio (mrq)7.08
Book Value Per Share (mrq)6.24

Cash Flow Statement

Operating Cash Flow (ttm)99.95M
Levered Free Cash Flow (ttm)127.83M